Please select user.
There are no topics yet.
Is there a template to follow for the Declaration of Conformity according to MDR?
1. When the ISO needs to be finished / audited? (e.g. when company is founded, when first device is sold or…? – E.g. Section 7: Product Realization is with planning etc. is running right now while the company is not yet founded.
2. Is English as language enough or is the country language additionally necessary?
3. Is the IVD guideline 98/79/EG (IVDD) and/or German “In-vitro-Diagnostika-Verordnung (IVDR)“ additionally necessary and incorporated in your toolkit? If not, can you recommend a toolkit for this? Background: In simple terms, the product is a special microscope with which a view of a tissue sample can be created and viewed. The interpretation of this image is done by a pathologist (unlike, for example, a blood pressure monitor, where the device interprets something). Staining of the tissue sample is done outside the device using standard procedures/products from appropriate manufacturers (e.g. H&E staining).
Thank you very much for letting me put my question. My main concern right now is, is it possible to prepare all the required documents without letting expansive consultant to do it for us? What would be the challenging part while preparing document by company staff? If we use Advisera Templates and experts advice for preparing our documents, how much time will it take to get thing done for class IIa medical device?
We manufacturer Class 1 medical devices and I am wondering what we are required for the Post Market Surveillance procedure?
I have already purchased the toolkit of ISO 13485 + MDR and
I noticed that in the Procedures there are references to ISO 9001.
But I don't see an ISO 9001 + ISO 13485 integrated toolkit on your website,
so if I want to get the ISO 9001 toolkit,
should I still keep it separate from ISO 13485?
I wonder if you can help me with one question, please? I have read that ISO 13485 2016 places emphasis on post-market surveillance, and this terms appears in the glossary. Yet I cannot find this term in the text of the standard, although I suppose the meaning is in Section 8. Is there anywhere in the standard that actually asks for post market surveillance please?
Vigilance is one requirement for MDR but cannot be found in the template. Is Vigilance included in 18_Post_Market_Surveillance?
I would like to ask about the documents included with the "ISO 13485 & MDR Integrated Documentation Toolkit toolkit with expert support"
We are a company with class I medical devices and are in the process of creating the SOPs to be compliant with MDR
Are your SOPs geared towards medical devices with higher classes (therefore more detailed and technical) or are they also suitable / can be modified for class 1 devices
For class 1 medical devices, we need to do SOPs for regulatory strategy; final product release; vigilance; and field safety corrective action. I don't seem to see those in the list of SOPs via the preview, and wanted to check if those are included or under a different name?
Also, does your company provide a way to identify in the SOPs which part of the relevant SOP is necessary for Class 1, and which parts are not? As we will likely only want to include the necessary info and not give extra unnecessary info.
I'm quality assurance and regulatory manager for a biotech company in Italy. We are going to do the ISO 9001, 14001 and 22716 standards the next june. I was wondering if 22716 and 13845 are comparable as certification scheme which are the difference between the two scheme?
Our company has bought few Advisera documents regarding ISO 13485 risk management and clinical evaluation. Can I ask you a question I have been struggling to find the answer? How often should those documents be updated? Clinical evaluation plan and review; risk management plan, file, review? We are producing class I medical devices.